§ 13-5303
224 words·~1 min read·
/md/health-general/13-5303A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
§13–5303.
(a)At the time of dispensing nPEP, a pharmacist registered with the Program shall:
(1)Screen the patient to determine that HIV exposure occurred within 72 hours before the dispensing;
(2)Determine whether the patient meets clinical criteria consistent with the most recent CDC Guidelines, including:
(i)The identification of any contraindicated medications; and
(ii)If applicable, exposure as the result of an alleged rape or sexual offense or alleged child sexual abuse;
(3)Subject to subsection
(b)of this section, determine whether an available standing order is appropriate for the patient and dispense nPEP in accordance with the most recent CDC Guidelines;
(4)Refer the patient to a disease intervention specialist within the Department for ongoing treatment; and
(5)Determine whether the patient has a primary care provider and:
(i)If the patient has a primary care provider, notify the provider that the patient was dispensed nPEP; or
(ii)If the patient does not have a primary care provider, provide the patient with a list of local primary care providers and clinics provided by the Department.
(b)If an available standing order is not appropriate for the patient, the pharmacist shall refer the patient to a primary care provider.
(c)A pharmacist may dispense nPEP in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.